Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
International Journal of Radiation Oncology, Biology, Physics
|
December 28, 2020
Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer
Anand Mahadevan, Shalini Moningi, Jimm Grimm, et al.
Anti-Cancer Drugs
|
January 25, 2003
Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody
Naomi R Schechter, David J Yang, Ali Azhdarinia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 2007
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma
David C Rice, W Roy Smythe, Zhongxing Liao, et al.
The Annals of Thoracic Surgery
|
October 24, 2007
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma
David C Rice, Craig W Stevens, Arlene M Correa, et al.
Magnetic Resonance Imaging
|
August 18, 2012
Promise and pitfalls of quantitative imaging in oncology clinical trials
Brenda F Kurland, Elizabeth R Gerstner, James M Mountz, et al.
Frontiers in Oncology
|
February 26, 2021
Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models
Anand Mahadevan, Bahman Emami, Jimm Grimm, et al.
Medical Physics
|
November 9, 2006
The management of respiratory motion in radiation oncology report of AAPM Task Group 76
Paul J Keall, Gig S Mageras, James M Balter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2019
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer
Jeffrey D Bradley, Chen Hu, Ritsuko R Komaki, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
International Journal of Radiation Oncology, Biology, Physics
|
December 28, 2020
Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer
Anand Mahadevan, Shalini Moningi, Jimm Grimm, et al.
Anti-Cancer Drugs
|
January 25, 2003
Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody
Naomi R Schechter, David J Yang, Ali Azhdarinia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 2007
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma
David C Rice, W Roy Smythe, Zhongxing Liao, et al.
The Annals of Thoracic Surgery
|
October 24, 2007
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma
David C Rice, Craig W Stevens, Arlene M Correa, et al.
Magnetic Resonance Imaging
|
August 18, 2012
Promise and pitfalls of quantitative imaging in oncology clinical trials
Brenda F Kurland, Elizabeth R Gerstner, James M Mountz, et al.
Frontiers in Oncology
|
February 26, 2021
Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models
Anand Mahadevan, Bahman Emami, Jimm Grimm, et al.
Medical Physics
|
November 9, 2006
The management of respiratory motion in radiation oncology report of AAPM Task Group 76
Paul J Keall, Gig S Mageras, James M Balter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2019
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer
Jeffrey D Bradley, Chen Hu, Ritsuko R Komaki, et al.
Page
of 3